# China NMPA Inspection - Xinghan Distribution Branch of Hanzhong Pharmaceutical Corporation, Shaanxi Province - August 24, 2018

Source: https://www.globalkeysolutions.net/records/china_inspection/xinghan-distribution-branch-of-hanzhong-pharmaceutical-corporation-shaanxi-province/c2b9ec8d-4a38-4efa-a0be-6db728d3beb5/
Source feed: China

> China NMPA unannounced inspection for Xinghan Distribution Branch of Hanzhong Pharmaceutical Corporation, Shaanxi Province published August 24, 2018. An unannounced inspection conducted by the Verification Center of the State Food and Drug Administration between May 24 and May 26, 2018, revealed sig

---

## Details

- Record Type: CHINA_INSPECTION
- Title: Notification of Unannounced Inspection of Xinghan Distribution Branch of Hanzhong Pharmaceutical Corporation, Shaanxi Province
- Company Name: Xinghan Distribution Branch of Hanzhong Pharmaceutical Corporation, Shaanxi Province
- Publication Date: 2018-08-24
- Product Type: drugs
- Summary: An unannounced inspection conducted by the Verification Center of the State Food and Drug Administration between May 24 and May 26, 2018, revealed significant violations at Xinghan Distribution Branch of Hanzhong Pharmaceutical Corporation, Shaanxi Province. The inspection, part of the annual plan for national pharmaceutical enterprises, identified three main issues. First, the company failed to issue invoices for some pharmaceutical sales to downstream customers. Second, it engaged in cash transactions for the sale of compound preparations containing special drugs. Third, its computer system lacked essential quality control functions for specific compound preparations, such as compound licorice tablets, which are explicitly prohibited from being sold to pharmaceutical wholesale companies, thereby posing a substantial safety hazard. These actions represent serious breaches of the "Good Supply Practice for Pharmaceutical Products" (GSP). As a result, the National Medical Products Administration (NMPA) has instructed the Shaanxi Provincial Food and Drug Administration to revoke Xinghan Distribution Branch's GSP certification and to launch an investigation into its suspected illegal and irregular business practices.

Company: https://www.globalkeysolutions.net/companies/xinghan-distribution-branch-of-hanzhong-pharmaceutical-corporation-shaanxi-province/0a8fd0fe-de84-47c4-a416-f7dc893c9c13/